EQS-Adhoc

    117 Aufrufe 117 0 Kommentare 0 Kommentare

    aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024

    Für Sie zusammengefasst
    • aap Implantate AG delays 2024 financial statements.
    • Audit completion pushed to June 2025 due to issues.
    • AGM rescheduled post financial statement publication.

    EQS-Ad-hoc: aap Implantate AG / Key word(s): Annual Report
    aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024

    29-Apr-2025 / 20:57 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
    The issuer is solely responsible for the content of this announcement.


    aap Implantate AG ("Company") announces that the auditor will no longer complete the audit of the annual and consolidated financial statements for the financial year 2024 in April. As a result, the Company will not be able to publish the annual and consolidated financial statements for 2024 within the statutory deadline of 30 April 2025. The company expects to be able to publish the annual and consolidated financial statements by June 2025.

    The reason for the delay is a number of details that have arisen in the Group's financial statement process, which can no longer be processed on time due to limited personnel resources.

    As a result, the company's Annual General Meeting will take place after the publication of the annual and consolidated financial statements for 2024 in summer 2025.

     

     

    Contact:
    If you have any questions, please contact:

    aap Implantate AG; R. Di Girolamo; Chairman of the Management Board / CEO; Lorenzweg 5;
    D-12099 Berlin, Tel.: +49/30/750 19 - 170; Fax: +49/30/750 19 - 290; r.digirolamo@aap.de


     

    End of Inside Information

    29-Apr-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com


    Language: English
    Company: aap Implantate AG
    Lorenzweg 5
    12099 Berlin
    Germany
    Phone: +49 (0) 30 75 019-0
    Fax: +49 (0) 30 75 019-111
    E-mail: info@aap.de
    Internet: www.aap.de
    ISIN: DE000A3H2101
    WKN: A3H210
    Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 2127118

     
    End of Announcement EQS News Service

    2127118  29-Apr-2025 CET/CEST





    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024 EQS-Ad-hoc: aap Implantate AG / Key word(s): Annual Report aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024 29-Apr-2025 / 20:57 CET/CEST …